JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 21 March 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02443-06v1
81/11/5737    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JAWORSKA, J.
Right arrow Articles by FLAMAND, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JAWORSKA, J.
Right arrow Articles by FLAMAND, L.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.02443-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

INHIBITION OF INTERFERON BETA GENE TRANSCRIPTION BY THE HUMAN HERPESVIRUS 6 IMMEDIATE-EARLY 1 PROTEIN

JOANNA JAWORSKA, ANNIE GRAVEL, KARIN FINK, NATHALIE GRANDVAUX, and LOUIS FLAMAND*

Laboratory of Virology, Rheumatology and Immunology Research Center, CHUQ Research Center and Faculty of Medicine, Laval University, Quebec, Quebec, Canada; Department of Biochemistry, Faculty of Medicine, University of Montreal and CHUM Research Center-Hôpital St-Luc, Montreal, Quebec, Canada

* To whom correspondence should be addressed. Email: Louis.Flamand{at}crchul.ulaval.ca.


   Abstract

Human Herpesviruses (HHV) are stealth pathogens possessing several decoy or immune evasion mechanisms favoring their persistence within the infected host. Of these viruses, HHV-6 is among the most successful human parasites, establishing life-long infections in nearly 100% of individuals around the world. To better understand this host-pathogen relationship, we determined whether HHV-6 could interfere with the development of the innate antiviral response by affecting interferon (IFN) biosynthesis. Using inducible cell lines and transient transfection assays, we have identified the immediate-early 1 (IE1) protein as a potent inhibitor of ifn-{beta} gene expression. IE1 from both HHV-6 variants were capable of suppressing ifn-{beta} gene induction. IE1 prevents ifn-{beta} gene expression triggered by Sendai virus (SeV) infection, double-stranded RNA (dsRNA) and dsDNA transfection or ectopic expression of ifn-{beta} gene activators such as RIG-I, MAVS, TBK-1, IKK{epsilon} or IRF3. While IFN-{beta} mRNA stability is not affected, IE1 expressing cells have reduced levels of dimerized IRF3 and nuclear translocated IRF3 in response to activation by TBK-1 or IKK{epsilon} kinases. Using nuclear extracts and gel shift experiments and we could demonstrate that in the presence of IE1, IRF3 does not bind efficiently to the IFN-{beta} promoter sequences. Overall these results indicate that the IE1 protein of HHV-6, one of the first viral proteins synthesized upon viral entry, is a potent suppressor of ifn-{beta} gene induction and likely contributes to favor the establishment and successful infection of cells by this virus.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.